ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
-1.23%
S&P ASX All Technology
2,968.80
-1.53%
Brent Oil
83.535
-2.75%
US Dollar vs AUD
1.54176
-0.16%
Bitcoin
57,111.33
-5.76%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Harrow Inc (HROW)

  7. Harrow Inc (HROW) News

HROW Harrow Inc

10.43
0.24 (2.36%)
Last Updated: 03:15:20
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Harrow Inc HROW NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.24 2.36% 10.43 03:15:20
Open Price Low Price High Price Close Price Previous Close
10.24 10.04 10.44 10.19
more quote information »

Recent News

Date Time Source Heading
25/4/202421:00BWHarrow Will Release First Quarter 2024 Financial Results..
02/4/202423:16BWMelt Pharmaceuticals Closes $24 Million Series B Preferred..
20/3/202422:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
20/3/202408:45BWHarrow Announces Fourth Quarter and Year-End 2023 Financial..
19/3/202422:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
06/3/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:00BWHarrow Will Release Fourth Quarter and Year-End 2023..
22/2/202411:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202411:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202408:15EDGAR2Form 8-K - Current report
16/2/202408:01BWHarrow Licenses Canadian Rights to Apotex for Five Branded..
10/2/202408:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202408:30EDGAR2Form 8-K - Current report
30/1/202407:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/1/202423:00BWHarrow Announces New Appointments to its Board of Directors
11/1/202423:00BWHarrow Announces Availability of VEVYE® (Cyclosporine..
10/1/202402:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202400:00EDGAR2Form 8-K - Current report
03/1/202423:15BWMelt Pharmaceuticals Provides Corporate Update
03/1/202423:00BWHarrow Partners with Leading Healthcare Market Access..
29/11/202323:00BWHarrow Completes Transfer of the TRIESENCE® New Drug..
20/11/202323:00BWHarrow to Present at Two Investor Conferences in November
17/11/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202311:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202308:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:34EDGAR2Form 8-K - Current report
14/11/202308:01BWHarrow Announces Third Quarter 2023 Financial Results
04/11/202307:52EDGAR2Form 8-K - Current report
30/10/202323:00BWHarrow Will Release Third Quarter 2023 Financial Results on..
24/10/202322:00BWHarrow Completes Transfer of NDAs and Launches FLAREX®,..
30/9/202306:01EDGAR2Form 8-K - Current report
29/9/202322:00BWHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
26/9/202322:00BWMelt Pharmaceuticals Announces Exclusive Development and..
21/9/202308:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202321:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202306:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:05EDGAR2Form 8-K - Current report
10/8/202306:01BWHarrow Announces Second Quarter 2023 Financial Results
31/7/202321:00BWHarrow Launches VIGAMOX® in the U.S.
26/7/202323:00BWHarrow to Announce Second Quarter 2023 Financial Results on..
22/7/202306:02EDGAR2Form 8-K - Current report
21/7/202309:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/7/202309:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202307:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/7/202321:00BWHarrow Prices $60 Million Public Offering of Common Stock
19/7/202312:55BWHarrow erwirbt US-amerikanische und kanadische..
19/7/202307:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/7/202307:00BWHarrow Acquires Santen’s Branded Ophthalmic Portfolio
19/7/202306:59EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
HROW
Harrow
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved